News

LipoScience Inc. announced the publication of the first large-scale real world study evidencing a link between low LDL-P and reduced cardiovascular disease (CVD) risk.

June 23, 2014 — BG Medicine Inc. earlier this year announced the issuance of patent 8,672,857, titled “Galectin-3 and Cardiac Resynchronization Therapy,” by the United State Patent and Trademark...

Alere announced a class I recall of its INRatio2 PT/INR professional test strips, part of the Alere lNRatio2 PT/INR monitoring system (professional use) which also consists of the INRatio2 monitor...

genetic testing for coronary artery disease

Improved understanding of the molecular mechanism of atherogenesis will help identify disease-related pathways and biomarkers that may also help to predict the future risk in asymptomatic...

Singulex Blood Test Clinical Study American Heart Association

Singulex Inc. presented new data at the American Heart Association Epidemiology and Prevention Council Conference highlighting research results using the company’s proprietary ultrasensitive...

April 23, 2014 — Philips Healthcare has completed its first field study for its Minicare handheld cardiac Troponin-I (cTn-I) blood test, demonstrating the platform’s potential to produce...

Data presented from two meta-analyses using the Atherotech Vertical Auto Profile (VAP) lipid panel showed the impact high-density lipoprotein (HDL) cholesterol and remnant lipoprotein (RLP)...

Roughly one out of three children screened for high cholesterol between the ages of 9 and 11 has borderline or high cholesterol, potentially placing them at greater risk for future cardiovascular...

April 10, 2014 — Patients presenting to the emergency department with an undetectable level of the blood biomarker high-sensitivity cardiac troponin T, and whose ECGs (electrocardiograms) show no...

LipoScience Inc. announced data showing that patients managed to a target LDL particle (LDL-P) number, as measured by LipoScience's NMR LipoProfile test, achieved a 22 to 25 percent greater...

Atherotech Diagnostics Lab opened its patient service center in Sarasota, Fla. 

Without administering a simple blood test in the first few days after surgery, 85 percent of the heart attacks...

HealthMed Holdings completed validation on a blood test that aims to identify individuals who are at risk of a...

Massachusetts General Hospital conducted a biomarker-guided therapy study of chronic heart failure patients with left ventricular systolic dysfunction over a 10-month period. Results of “Head-to-...

Traditional fingerstick screening for glucose and lipids is proving inadequate when identifying near-term ...

CardioDx Inc. is a molecular diagnostics company specializing in cardiovascular genomics. It...

A new “fluid biopsy” technique that could identify patients at high risk of a heart attack by...

ACC, iPad cardiology apps

DAIC readers chose the following stories as the most popular content in 2013, based on website analytics.

Combining genetic data with clinical information to determine the initial dosage of the blood thinner warfarin, used to prevent blood clots in the circulatory system, was no more effective in...

antiplatelet therapy clinical trial blood test platelet function corgenix

study conducted in Ireland found that aspirin does not adequately protect 20 percent of patients with...